NanoString's Hyb & Seq(TM) enables liquid biopsy by direct capture and sequencing
NanoString announced the company has demonstrated the capability of its Hyb & Seq technology to perform liquid biopsy measurement. The sequencing of circulating cell-free DNA from blood is a promising non-invasive tool for clinical oncology and offers numerous advantages over current NGS methods. September 18, 2017